Table 1.

Incidence proportion and median survival in patients with metastases at diagnosis

Metastases subtype	Incidence Proportion of all-cause mortality cohort, %	Median survival (IQR), month	Incidence Proportion of cancer-specific mortality cohort, %	Median survival (IQR), month
Bone	0.9	5.0 (1.0–11.0)	1.6	4.0 (1.0–9.0)
Liver	6.7	9.0 (2.0–25.0)	9.9	6.0 (1.0–19.0)
Lung	5.8	9.0 (2.0–24.0)	8.8	6.0 (1.0–21.0)
Brain	0.2	3.5 (1.0–11.0)	0.3	3.0 (1.0–7.0)
Lymph	0.9	4.0 (1.0–7.0)	0.5	1.5 (1.0–5.75)
Bone only	0.4	7.0 (2.0–19.5)	0.6	6.0 (2.0–14.5)
Liver only	0.1	10.0 (2.0–28.0)	6.9	7.0 (1.0–20.0)
Lung only	3.9	11.0 (2.0–25.0)	5.8	8.0 (1.0–22.0)
Lymph only	0.5	5.0 (2.0–8.0)	0.2	2.0 (1.0–4.5)
Brain only	4.8	4.0 (2.0–12.0)	0.2	2.5 (2.0–7.75)

Abbreviations: IQR Interquartile range